Patent Infringement: MSD sues firm in Delhi HC over diabetes drug Sitagliptin Medical Dialogues Team20 Jun 2021 11:30 AM ISTNew Delhi: In a major victory for Merck Sharp and Dohme (MSD) Corp, the Delhi High Court has restrained Solitaire Pharmacia Private from infringing...
Delhi HC Restrains Firm From Infringing on MSD Diabetes Drug Sitagliptin Medical Dialogues Team8 Jun 2021 8:36 PM ISTNew Delhi: In a major relief to Merck Sharp & Dohme Corp, the Delhi High Court has barred YMS Laboratories Private Limited from infringing on...
Himachal drugmaker agrees to destroy infringed stock of Merck Diabetes Drug Sitagliptin Medical Dialogues Team7 April 2021 6:42 PM ISTNew Delhi: In a relief to Merck, Hariom Pharmachem has agreed to destroy the stock of infringed products of Merck's popular diabetes drug Sitagliptin,...
Citing voglibose, sitagliptin incompatibility, CDSCO panel rejects Hetero Labs proposal for antidiabetic FDC drug Medical Dialogues Team13 March 2021 6:50 PM ISTNew Delhi: In a setback to Hetero Labs, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
Sitagliptin, insulin combo better than insulin alone for treatment of LADA: Study Medha Baranwal16 Feb 2021 6:15 AM ISTChina: Sitagliptin plus insulin treatment improves insulin sensitivity and maintain β-cell function in latent autoimmune diabetes in...
Sitagliptin may not control blood sugar during bypass surgery in diabetics: Study Medha Baranwal30 Dec 2020 11:30 AM ISTUSA: Perioperative administration of sitagliptin in diabetes patients undergoing bypass surgery does not prevent hyperglycemia or complications, finds...
Sitagliptin does not control blood sugar in paediatric patients with T2D, warns FDA MD Bureau17 Dec 2020 11:16 AM ISTUS Food and Drug Administration has recently approved labelling changes in Sitagliptin drug stating that sitagliptin and its combination with...
Gliclazide modified release better second-line treatment than sitagliptin for type 2 diabetes patients on Metformin- Study Hina Zahid9 Oct 2020 9:44 AM ISTUK: Gliclazide modified release (MR) is more effective in reducing blood sugar levels than sitagliptin in type 2 diabetes (T2D) patients already...
Sitagliptin improves survival in diabetes patients with COVID-19: Study Dr. Kamal Kant Kohli30 Sept 2020 11:00 AM ISTBOSTON - Researchers have found in a new multicenter observational study in Italy that Sitagliptin, a Diabetes drug improves survival in diabetes...
Aurobindo Pharma in legal battle with Merck over blockbuster diabetes drug Janumet Farhat Nasim26 Aug 2020 11:30 AM ISTHyderabad: In a major setback to Aurobindo Pharma, Merck Sharp & Dohme Corp, a subsidiary of Merck & Co has filed a petition in a US court...
Delhi HC restrains firm from infringing Merck diabetes drug Sitagliptin Farhat Nasim28 Jun 2020 11:15 AM IST"It appears that if Merck Sharp & Dohme Corp are not protected, their interest would get jeopardized. Furthermore, it would also affect the interest...
Sitagliptin decreases blood sugar and visceral fat in women with PCOS Medha Baranwal2 Feb 2020 1:00 PM ISTNashville, TN: Sitagliptin decreases peak blood sugar and visceral adiposity (VAT) in women with the polycystic ovarian syndrome (PCOS), according to...
